Welcome to the 12th Annual Miami Neuroscience Symposium.

Neuroscience is a rapidly advancing field, with new discoveries, technologies and treatment modalities emerging regularly. The Miami Neuroscience Symposium presents a comprehensive curriculum dedicated to cutting-edge, evidence-driven approaches for clinicians and healthcare practitioners specializing in the treatment and support of patients within neuroscience, from emergency care to rehabilitation. The distinguished faculty will guide engaging sessions, showcasing intricate case studies and pioneering treatment approaches.

What to Expect

• Keeping Pace with Advances: Neuroscience research continually uncovers new insights into the brain, nervous system and associated disorders. The distinguished faculty will guide engaging sessions to share the latest innovative and evidence-based clinical methodologies, designed to enhance patient outcomes across the entire spectrum of neuroscience care.
• Interdisciplinary - Interprofessional Collaboration: Neuroscience care often requires collaboration across multiple disciplines, including neurology, neurosurgery, psychiatry, pharmacy, nursing, rehabilitation, and more. The Miami Neuroscience Symposium will facilitate interdisciplinary learning and foster collaboration among healthcare professionals.
• Enhancing Clinical Skills: By presenting complex case studies and innovative treatment strategies, this symposium will help clinicians enhance their diagnostic and therapeutic skills. The expert faculty will provide practical insights that can be directly applied to patient care.
• Networking and Professional Development: The Miami Neuroscience Symposium will bring together professionals from diverse backgrounds, creating networking opportunities and fostering professional development. Attendees can exchange ideas, share experiences and build relationships with colleagues and experts in the field.

Topics covered encompass a wide range of areas, including:

• AI and the future integration in neuroscience healthcare.
• Movement disorders: diagnosis, management and treatment.
• Emergency management of neurological conditions.
• Neurocritical care and acute interventions.
• Multidisciplinary approaches to rehabilitation and sustained patient care.

Who Should Attend

Adult and Pediatric Neurologists, Neurosurgeons, Stroke Neurologists, Neuroradiologists, Diagnostic Radiologists, Critical Care Physicians, Neuro Intensive Care Physicians, Emergency Medicine Physicians, Internal Medicine Physicians, Interventional Neuroradiologists, Family Physicians, General Internists, Neuropsychologists, Physician Assistants, Critical Care and Neuroscience Nurses, Neurosurgery Nurses, Nurse Practitioners, Physical Therapists, Respiratory Therapists, Dietitians, Clinical Neurophysiology Technicians, Clinical Pharmacists, Rehabilitation and Pain Management Specialists, as well as other specialists interested in the field of neuroscience.

We gratefully acknowledge Susan and Norman Scott and family for their sponsorship of the session in which Victor Faradji, M.D., is lecturing.

Commercial Support

Baptist Health gratefully acknowledges the educational grants provided by Boston Scientific, Cerenovus, Eisai, Medtronic, Terumo Neuro, and Supernus Pharmaceuticals.

Learning Objectives

Upon completion of this symposium, participants should be better able to:

• Recognize the interplay between different healthcare disciplines in the assessment, diagnosis and management of neurological disorders, such as stroke, epilepsy, Parkinson's disease, multiple sclerosis and Alzheimer's disease.
• Discuss the opportunities and limitations of AI-driven solutions in neuroscience research and healthcare.
• Identify clinical features and diagnostic criteria for different movement disorders to facilitate accurate diagnosis and management.
• Utilize a multidisciplinary approach to managing movement disorders, involving neurologists, neurosurgeons, physical therapists, occupational therapists and speech-language pathologists.
• Recognize the clinical presentations and differential diagnosis of ischemic stroke, hemorrhagic stroke and transient ischemic attack (TIA), facilitating timely and accurate diagnosis.
• Apply principles of neuroprotective strategies and secondary injury prevention in critically ill neurological patients, including temperature management, glycemic control and seizure prophylaxis.
• Utilize current, evidence-based guidelines and treatment algorithms for the management of epilepsy, including pharmacological interventions and surgical options.
• Discuss emerging research in identification and management strategies in neurocognitive disorders.
• Describe the principles of neurorehabilitation and the goals of rehabilitation in individuals with neurological disorders, including maximizing functional independence, enhancing quality of life and promoting community reintegration.
• Recognize the indications for neurosurgical interventions in various neurological conditions, including brain tumors, vascular malformations, traumatic brain injury, spinal cord compression and peripheral nerve disorders.
• Describe the pathophysiology of neuromuscular disorders, including autoimmune diseases, hereditary neuropathies, myopathies, motor neuron diseases and neuromuscular junction disorders.
• Recognize the clinical manifestations and diagnostic criteria for common neuromuscular disorders.
• Discuss the role of advanced diagnostic tests and neurophysiological studies in the evaluation of neuromuscular disorders and neuroimmunological diseases.
• Apply the latest evidence-based guidelines and protocols for acute stroke management.
• Discuss the role of neuroendovascular procedures in the treatment of acute stroke and prevention of recurrent stroke.

Registration and Fees

* Registration must be accompanied by a letter from the Fellowship/Residency Director.

** Not eligible for early bird rate.

Cancellation Policy

Cancellations must be received by Friday, October 25, 2024 to receive a refund of the registration fee, less a $35 administrative fee. Registration fees are not refundable after Friday, October 25, 2024.